High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

Seldin, D C; Andrea, N; Berenbaum, I; Berk, J L; Connors, L; Dember, L M; Doros, G; Fennessey, S; Finn, K; Girnius, S; Lerner, A; Libbey, C; Meier-Ewert, H K; O'Connell, R; O'Hara, C; Quillen, K; Ruberg, F L; Sam, F; Segal, A; Shelton, A; Skinner, M; Sloan, J M; Wiesman, J F; Sanchorawala, V

Seldin, D C; Andrea, N; Berenbaum, I; Berk, J L; Connors, L; Dember, L M; Doros, G; Fennessey, S; Finn, K; Girnius, S; Lerner, A; Libbey, C; Meier-Ewert, H K; O'Connell, R; O'Hara, C; Quillen, K; Ruberg, F L; Sam, F; Segal, A; Shelton, A; Skinner, M; Sloan, J M; Wiesman, J F; Sanchorawala, V.

Affiliation

Seldin DC; Clinical Trials Office, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA.

Amyloid ; 18 Suppl 1: 127-9, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21838459

Subject(s)

Amyloidosis/therapy; Immunoglobulin Light Chains; Stem Cell Transplantation; Amyloidosis/drug therapy; Amyloidosis/immunology; Amyloidosis/physiopathology; Amyloidosis/surgery; Combined Modality Therapy; Dose-Response Relationship, Drug; Humans; Survival Rate; Transplantation, Autologous

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Light Chains / Stem Cell Transplantation / Amyloidosis Limits: Humans Language: En Journal: Amyloid Journal subject: BIOQUIMICA Year: 2011 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google